The pharmaceutical landscape experiencing a revolution with the emergence of novel glucagon-like peptide-1 (GLP-1) receptor agonists. These innovative drugs demonstrate immense potential in managing type 2 diabetes https://keithokow271590.wikissl.com/1627425/novel_glp_1_receptor_agonists_retatrutide_cagrillintide_tirzepatide_and_semaglutide